Dianthus Therapeutics, Inc. /DE/ Increase (Decrease) in Prepaid Expense and Other Assets
Dianthus Therapeutics, Inc. /DE/ (DNTH) reported Increase (Decrease) in Prepaid Expense and Other Assets of $5.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- Dianthus Therapeutics, Inc. /DE/ increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $3.20M.
- Dianthus Therapeutics, Inc. /DE/ increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $2.33M, a 21.85% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.12M, a 195.57% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $35.00K, a 90.74% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ increase (decrease) in prepaid expense and other assets for fiscal 2025 was $235.00K, a 85.32% decline from fiscal 2024.
- Dianthus Therapeutics, Inc. /DE/ increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.60M.
- Dianthus Therapeutics, Inc. /DE/ increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$123.00K, a 119.49% decline from fiscal 2022.
- Dianthus Therapeutics, Inc. /DE/ increase (decrease) in prepaid expense and other assets for fiscal 2022 was $631.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $5.53M 10-Q · filed 2026-08-04 | $4.41M derived: sum of 3 quarters · filed 2026-08-04 | $4.44M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $2.33M 10-Q · filed 2026-05-05 | $1.21M derived: sum of 2 quarters · filed 2026-05-05 | $1.25M derived: sum of 3 quarters · filed 2026-05-05 | $653.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$1.09M derived: sum of 2 quarters · filed 2026-03-09 | -$1.68M derived: sum of 3 quarters · filed 2026-08-04 | $235.00K 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$557.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.36M 10-Q · filed 2025-11-05 | $2.53M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$592.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.32M 10-Q · filed 2026-08-04 | $2.49M derived: sum of 3 quarters · filed 2026-08-04 | $2.87M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $1.91M 10-Q · filed 2026-05-05 | $3.09M derived: sum of 2 quarters · filed 2026-05-05 | $3.46M derived: sum of 3 quarters · filed 2026-05-05 | $3.75M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.55M derived: sum of 2 quarters · filed 2026-03-09 | $1.84M derived: sum of 3 quarters · filed 2026-03-09 | $1.60M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $669.00K derived: sum of 2 quarters · filed 2025-11-05 | $428.00K 10-Q · filed 2025-11-05 | $2.85M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $50.00K 10-Q · filed 2025-08-07 | $2.47M derived: sum of 3 quarters · filed 2025-08-07 | $583.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$241.00K 10-Q · filed 2025-05-12 | $2.18M derived: sum of 2 quarters · filed 2025-05-12 | $292.00K derived: sum of 3 quarters · filed 2025-05-12 | -$248.00K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $533.00K derived: sum of 2 quarters · filed 2025-03-11 | -$7.00K derived: sum of 3 quarters · filed 2025-03-11 | -$123.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.43M derived: sum of 2 quarters · filed 2024-11-07 | -$2.55M 10-Q · filed 2024-11-07 | -$2.78M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$540.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$656.00K 10-Q · filed 2024-08-08 | -$2.52M 10-Q · filed 2023-08-03 | -$887.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.13M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$116.00K 10-Q · filed 2024-05-09 | -$647.00K 10-Q · filed 2023-05-15 | -$347.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.67M derived: sum of 3 quarters · filed 2024-05-09 | $647.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.78M derived: sum of 2 quarters · filed 2024-03-21 | $763.00K derived: sum of 3 quarters · filed 2024-03-21 | $631.00K 10-K · filed 2024-03-21 | -$206.00K 10-K · filed 2023-03-23 | |||
| 2022-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $994.00K derived: sum of 2 quarters · filed 2023-11-09 | $862.00K 10-Q · filed 2023-11-09 | $46.00K 10-Q · filed 2022-11-03 | -$34.00K derived: sum of 4 quarters · filed 2023-12-21 | |||
| 2022-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.15M 10-Q · filed 2023-08-03 | -$2.05M derived: sum of 3 quarters · filed 2023-12-21 | -$568.00K derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2022-03-31 | -$132.00K 10-Q · filed 2023-05-15 | -$1.03M derived: sum of 2 quarters · filed 2023-12-21 | $450.00K derived: sum of 3 quarters · filed 2023-12-21 | $34.00K derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2021-12-31 | -$896.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-12-21 | $582.00K derived: sum of 2 quarters · filed 2023-12-21 | $166.00K derived: sum of 3 quarters · filed 2023-12-21 | $271.00K 8-K · filed 2023-12-21 | $1.07M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.06M derived: sum of 2 quarters · filed 2022-11-03 | $1.17M 10-Q · filed 2022-11-03 | $1.32M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$311.00K 10-Q · filed 2022-08-04 | -$154.00K derived: sum of 3 quarters · filed 2022-08-04 | -$995.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $105.00K 10-Q · filed 2022-05-16 | $262.00K derived: sum of 2 quarters · filed 2022-05-16 | -$579.00K derived: sum of 3 quarters · filed 2022-05-16 | $71.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$684.00K derived: sum of 2 quarters · filed 2022-03-08 | -$34.00K derived: sum of 3 quarters · filed 2022-03-08 | -$1.42M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$841.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$191.00K derived: sum of 2 quarters · filed 2021-11-04 | -$1.58M 10-Q · filed 2021-11-04 | -$2.13M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$738.00K 10-Q · filed 2021-08-05 | -$1.28M derived: sum of 3 quarters · filed 2021-08-05 | -$7.36M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$1.39M 10-Q · filed 2021-05-06 | -$1.93M derived: sum of 2 quarters · filed 2021-05-06 | -$8.01M derived: sum of 3 quarters · filed 2021-05-06 | -$5.04M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$546.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$6.63M derived: sum of 2 quarters · filed 2021-03-03 | -$3.66M derived: sum of 3 quarters · filed 2021-03-03 | $1.36M 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | -$6.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$3.11M derived: sum of 2 quarters · filed 2020-11-05 | $1.91M 10-Q · filed 2020-11-05 | $1.64M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $7.99M 10-Q · filed 2020-08-06 | $7.71M derived: sum of 3 quarters · filed 2020-08-06 | $8.41M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $5.02M 10-Q · filed 2020-05-07 | $4.75M derived: sum of 2 quarters · filed 2020-05-07 | $5.44M derived: sum of 3 quarters · filed 2020-05-07 | $6.77M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $419.00K derived: sum of 2 quarters · filed 2020-03-03 | $1.75M derived: sum of 3 quarters · filed 2020-03-03 | $1.81M 10-K · filed 2020-03-03 | ||||
| 2018-09-30 | $693.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $2.02M derived: sum of 2 quarters · filed 2019-11-13 | $2.08M 10-Q · filed 2019-11-13 | $2.66M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.39M 10-Q · filed 2019-08-08 | $1.97M derived: sum of 3 quarters · filed 2020-03-03 | $2.11M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | $60.00K 10-Q · filed 2019-05-09 | $634.00K derived: sum of 2 quarters · filed 2020-03-03 | $777.00K derived: sum of 3 quarters · filed 2020-03-03 | |||||
| 2017-12-31 | $574.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $717.00K derived: sum of 2 quarters · filed 2020-03-03 | $895.00K 10-K · filed 2020-03-03 | |||||
| 2017-09-30 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $321.00K 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | $178.00K 10-Q · filed 2018-08-09 | |||||||
| 2016-12-31 | $41.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |